Fny Investment Advisers, LLC Neoleukin Therapeutics, Inc. Transaction History
Fny Investment Advisers, LLC
- $208 Million
- Q3 2024
A detailed history of Fny Investment Advisers, LLC transactions in Neoleukin Therapeutics, Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 25 shares of NLTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25Holding current value
$0% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NLTX
# of Institutions
1Shares Held
199KCall Options Held
0Put Options Held
0About Neoleukin Therapeutics, Inc.
- Ticker NLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 42,579,900
- Description
- Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...